# Jinling Biopharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jinling-biopharmaceuticals

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Angel (Sep 8, 2025)
- Investors on record: 2

## About

Founded in 2025 and based in Suzhou, China, Jinling Biopharmaceuticals provides medical research and experimental development platforms. In September 2025, Jinling Biopharmaceuticals closed an angel round funding from new investors NRL Capital, and Suzhou Xincheng Private Equity Fund Management.
The company primarily engages in medical research and experimental development, medical technology research and development, and other related businesses.
Revenue is generated through providing platforms of medical research and experimental.
The company will further promote the development of medical research and enhance the technology and service capabilities of the testing platform.

## Funding rounds

- Angel, Sep 8, 2025 — NRL Capital, Suzhou Xincheng Private Equity Fund Management

## Investors

- NRL Capital (https://capitalatlas.ai/funds/nrl-capital) — Angel
- Suzhou Xincheng Private Equity Fund Management (https://capitalatlas.ai/funds/suzhou-xincheng-private-equity-fund-management) — Angel